Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Biomarker Discovery Outsourcing Services Market

Biomarker Discovery Outsourcing Services Market Trends

Report ID: GMI7722
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Biomarker Discovery Outsourcing Services Market Trends

Developing biomarkers is a demanding and resource-intensive undertaking that necessitates expertise in biotechnology, bioinformatic services, and regulatory affairs.
The enhanced focus on cost-effectiveness and resource optimization has driven pharmaceutical and biopharmaceutical firms to increasingly adopt outsourcing services for biomarker discovery. This collaboration was aimed to innovate solution and to streamline the transition from research to clinical application, advancing precision medicine opportunities.
Furthermore, CRISPR-based methodologies and single-cell analysis represent emerging technologies within the realm of biomarker discovery services. These technologies facilitate the swift identification of mutations and provide a more accurate characterization of molecular targets.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global biomarker discovery outsourcing services industry size was valued USD 11.4 billion in 2023 and is expected to reach USD 33.7 billion by 2032, propelled by a rising need for personalized medicine, prompting a surge in R&D activities.

The surrogate endpoints segment is expected to reach USD 16.2 billion by 2032 as they play a pivotal role in predicting treatment efficacy and safety during drug development.

North America biomarker discovery outsourcing services industry is anticipated to record around 12.3% CAGR from 2024 to 2032 as it is the primary hub for innovative pharmaceutical and biotechnology research.

Bio-Rad Laboratories, Inc., Parexel International (MA) Corporation, Svar Life Science, Sino Biological, Inc, ICON plc., Integrated DNA Technologies, Inc., Almac Group Limited, REPROCELL Inc., Frontage Labs, Biomcare ApS, Crown Bioscience, RayBiotech, Inc., Excelra, and Evotec.